OHSU in the news

CytoDyn Takes Steps towards a Brighter Future

Pharma's Almanac February 06, 2023
Vancouver-based CytoDyn chief executive officer highlights partnership with OHSU to develop a longer-active version of an experimental drug called leronlimab in an interview published by Pharma’s Almanac. For more on the OHSU work led by Jonah Sacha, Ph.D., see OHSU News.

To Your Health: World Cancer Day

The News Guard (Lincoln City) February 04, 2023
The News Guard (Lincoln City) interviews Flavio Rocha, M.D., about the latest breakthroughs in cancer research for World Cancer Day.

EzriCare Eye Drops Recalled as CDC Investigates Link to Drug-Resistant Bacterial Infections

Health magazine February 04, 2023
In a story about a brand of eye drops being associated with a bacterial eye infection outbreak, Brooke Harkness, O.D, provides recommendations to avoid bacterial eye infections, including not sleeping in contacts, not washing contacts with tap water and using eye drops that are available in small containers or in a bottle with a contamination-preventing valve and filter.
See more stories